$ZYME stock has now fallen 8% today, according to our price data from Polygon. There has been approximately $11,980,674 of trading volume.
Here is what we see in our data on $ZYME (you can track the company live on Quiver's $ZYME stock page):
$ZYME Insider Trading Activity
$ZYME insiders have traded $ZYME stock on the open market 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $ZYME stock by insiders over the last 6 months:
- ADAM SCHAYOWITZ (EVP, Head of R&D) sold 13,832 shares for an estimated $357,557
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$ZYME Hedge Fund Activity
We have seen 90 institutional investors add shares of $ZYME stock to their portfolio, and 101 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- NOMURA ASSET MANAGEMENT INTERNATIONAL INC. added 889,802 shares (+inf%) to their portfolio in Q2 2026, for an estimated $23,259,424
- PERCEPTIVE ADVISORS LLC added 672,875 shares (+19.2%) to their portfolio in Q2 2026, for an estimated $17,588,952
- MPM BIOIMPACT LLC removed 565,249 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $14,775,608
- FISHER ASSET MANAGEMENT, LLC added 537,837 shares (+759.9%) to their portfolio in Q3 2026, for an estimated $14,247,302
- CAPRICORN FUND MANAGERS LTD removed 486,529 shares (-100.0%) from their portfolio in Q3 2026, for an estimated $12,888,153
- FMR LLC removed 472,404 shares (-67.2%) from their portfolio in Q3 2026, for an estimated $12,513,981
- DIMENSIONAL FUND ADVISORS LP removed 464,507 shares (-46.7%) from their portfolio in Q3 2026, for an estimated $12,304,790
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
$ZYME Price Targets
Multiple analysts have issued price targets for $ZYME recently. We have seen 3 analysts offer price targets for $ZYME in the last 6 months, with a median target of $37.0.
Here are some recent targets:
- Gregory Renza from Truist Securities set a target price of $31.0 on 07/07/2026
- Eva Fortea Verdejo from Wells Fargo set a target price of $37.0 on 06/30/2026
- Robert Burns from HC Wainwright & Co. set a target price of $46.0 on 06/03/2026
You can track data on $ZYME on Quiver Quantitative.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.